Scout Investments’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$12M Sell
132,999
-21,520
-14% -$1.86M 0.32% 116
2024
Q2
$12.7M Sell
154,519
-14,810
-9% -$1.09M 0.34% 114
2024
Q1
$11.2M Sell
169,329
-10,777
-6% -$665K 0.27% 124
2023
Q4
$10.2M Sell
180,106
-8,092
-4% -$424K 0.26% 126
2023
Q3
$10.4M Sell
188,198
-5,475
-3% -$324K 0.24% 120
2023
Q2
$12.3M Sell
193,673
-5,773
-3% -$352K 0.25% 125
2023
Q1
$10.3M Sell
199,446
-2,270
-1% -$110K 0.21% 134
2022
Q4
$9.28M Sell
201,716
-3,349
-2% -$157K 0.19% 134
2022
Q3
$10.4M Buy
205,065
+4,689
+2% +$234K 0.22% 131
2022
Q2
$9.13M Buy
200,376
+5,790
+3% +$259K 0.18% 144
2022
Q1
$9.04M Sell
194,586
-258
-0.1% -$11.5K 0.14% 161
2021
Q4
$9.79M Sell
194,844
-4,390
-2% -$227K 0.14% 185
2021
Q3
$10.6M Sell
199,234
-6,847
-3% -$386K 0.16% 186
2021
Q2
$12.6M Buy
206,081
+20,289
+11% +$1.08M 0.19% 166
2021
Q1
$9.06M Buy
+185,792
New +$8.71M 0.14% 226

Other funds holding LMAT

Scout Investments's LMAT Position: Q3 2024 in Review

Scout Investments reduced its LeMaitre Vascular (LMAT) stake by 14% in Q3 2024, selling an estimated $1.86M and leaving 132,999 shares worth $12M. The position accounts for 0.32% of the portfolio, ranked #116.

Scout Investments first reported a position in LMAT in Q1 2021 and has held it in 15 quarters since. The position peaked at $12.7M in Q2 2024. 291 funds tracked by Wall St. Rank hold LMAT as of Q3 2024.

  • Scout Investments held 132,999 shares of LeMaitre Vascular worth $12M as of Q3 2024.
  • Scout Investments sold 21,520 LeMaitre Vascular shares in Q3 2024, an estimated $1.86M.
  • LeMaitre Vascular made up 0.32% of Scout Investments's portfolio in Q3 2024, its #116 holding.
  • Scout Investments first reported a position in LeMaitre Vascular in Q1 2021 and has held it in 15 quarters since.
  • Scout Investments's LeMaitre Vascular position peaked at $12.7M in Q2 2024.
  • 291 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2024.

Based on Scout Investments's 13F filing for Q3 2024, filed 12 Nov 2024.